RxDoctor Payments Data

Kristen Roberts, APRN

Family · Apopka, FLNPI 1790237196

Payments from drug & device makers

$298in general payments, 2019–2025

Across 10 payments — averaging $29.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$130
  • Organon$31
  • Lilly USA, LLC$29
  • Pfizer$26
  • Ferring Pharmaceuticals Inc.$24
  • Abbott$23
  • plus $36 from 3 others

What the payments were for

  • Food & beverage$298100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$298 in reported general payments places this provider in the 45th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$15,864
Medicare patients
87
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$64,230
EliquisApixaban76$52,029
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$45,162
JardianceEmpagliflozin29$30,915
MounjaroTirzepatide19$19,373
RybelsusSemaglutide16$14,571
Breo ElliptaFluticasone/Vilanterol14$5,044
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,086
Albuterol Sulfate HfaAlbuterol Sulfate50$1,891
Rosuvastatin Calcium134$1,059
Fluticasone Propionate94$989
Levothyroxine Sodium135$925
Atorvastatin Calcium116$896
Gabapentin86$844
Potassium Chloride38$797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$130$78,80269 claims
PfizerEliquis$26$52,02976 claims
Lilly USA, LLCMounjaro$29$19,37319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 14,618 family providers in Florida.

Other family in Apopka

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →